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The Effect of Fatigue and Pain Self- Efficacy 
on Health-Related Quality of Life Among 
Patients with Multiple Sclerosis
Fevronia Adamopoulou1, Victoria Alikari2, Sofia Zyga2, Maria Tsironi2, Fotini 
Tzavella2, Natalia Giannakopoulou3, Paraskevi Theofilou4,5
ABSTRACT
Introduction: Health-related quality of life is a 
major issue among patients with Multiple sclerosis 
(MS). Aim: To explore the effect of fatigue and pain 
self-efficacy on health-related quality of life among 
patients with MS. Methods: Between March and 
May 2018, 85 MS patients from a large Hospital 
of Athens region completed the questionnaires: 
a) Missoula-VITAS Quality of Life Index-15, which 
examines 5 dimensions of quality of life, b) Pain Self 
Efficacy Questionnaire which measures the pain 
self-efficacy that an individual perceives, c) Fatigue 
Assessment Scale (FAS) which measures fatigue, 
d) a questionnaire about the sociodemographic 
elements. Statistical analysis was performed using 
the IBM SPSS Statistics version 21. The significance 
level was set up to 0.001. Results: Fatigue might 
predict the dimension of quality of life “Function” 
while Pain Self-Efficacy might, also, predict the 
dimension of quality of life “Interpersonal”. A strong 
correlation was found between the dimensions of 
quality of life “Well-being” and “Transcendent” and 
between “Interpersonal” and Pain Self-Efficacy. The 
total score of fatigue was strongly correlated with 
Physical Fatigue and very strongly correlated with 
Mental Fatigue. Conclusion: Fatigue and Pain Self-
Efficacy are important predictors of the dimensions 
of quality of life among patients with MS. Pain in 
MS has to be taken into serious consideration in 
every patient with MS.
Keywords: fatigue, pain self-efficacy, multiple 
sclerosis, quality of life.
1. INTRODUCTION
Multiple sclerosis (MS) is a chronic neuro-
logical condition with many and different symp-
toms. MS symptoms are variable and unpre-
dictable such as fatigue which occurs in about 
80% of people, pain, spasms, weakness (which 
results from deconditioning of unused muscles 
or damage to nerves that stimulate muscles), 
depression and cognitive problems (1).
The symptom of pain is also a common fea-
ture of well-established MS and has been docu-
mented as a significant symptom experienced 
by patients with MS (2). Chronic pain is usually 
associated with myelopathy and is common in 
women and in older individuals with duration of 
disease greater than 5 years. The major chronic 
pain syndromes are back pain, and painful leg 
spasms (3). Pain is present in more than half 
of the cases and it adopts many aspects which 
most of the times ruin the patients’ quality of 
life. The ability to develop patients’ pain self-
efficacy in order to rely on them contributes 
positively to their Quality of life (QoL). When 
patients manage the various symptoms of the 
disease and meet their daily needs, they are able 
to prioritize and cope well with everyday life, 
thus improving their QoL (4).
Fatigue is the most prevalent issue for MS 
patients. It presents in 75-95% of patients with 
MS and it is reported as the worst symptom of 
the disease, which is associated with various 
health problems. Fatigue is defined as a feeling 
of lack of energy, weakness, and aversion to ef-
fort. Fatigue can occur at all stages of the disease 
and can affect QoL, depression, anxiety, motor 
function, and sleep patterns (5, 6).
Studies have shown that fatigue has a sub-
stantial impact on QoL in persons with MS by 
reducing physical stamina, interfering with the 
performance of responsibilities at home and 
work, and limiting social duties. Apart from 
their daily activities which are restricted, pa-
tients’ social relationships are limited, as well. 
This happens because many of these patients 
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confine their activities at home because of their symptoms, 
the fatigue or the pain that may feel or because they have to 
take their medications (interferon or cortisone injections) 
(7). In addition, fatigue has been inversely correlated with 
aspects of QoL in cross-sectional studies of MS patients (8, 
9). Fatigue is accused of the poor QoL more than weakness, 
spasticity, motor problems or urinary disorders.
2. AIM
The aim of the study was to explore the effect of fatigue 
and pain self- efficacy on health-related QoL among pa-
tients with multiple sclerosis (MS).
3. METHODS
Patients
In this cross-sectional study, 114 participants from 
“Agioi Anargyroi” Hospital of Kifissia were recruited. “Agioi 
Anargyroi” Hospital of Kifissia is one of the largest hospi-
tals for patients with variable neurological health issues. 
The inclusion criteria were: ≥18 years old, be Greeks, able 
to understand and speak fluently the Greek language and 
have the cognitive ability to answer the questionnaires. 
The participants who were not Greek, couldn’t write or had 
problems with their verbal speech were excluded from the 
study. The final sample consisted of 85 patients (response 
rate 74, 5%) (Figure 1). The study took place between 
March-May 2018.
Measures
Missoula-VITAS Quality of Life Index-15 (MVQoLI-15)
The first instrument was the Greek version of Missoula-
VITAS Quality of Life Index-15 (MVQoLI-15) in order to 
measure HRQoL (10) and includes information about a 
chronic illness (11). The tool seeks to describe the qualita-
tive and subjective experience of QoL in a way that can be 
quickly interpreted by professional caregivers (12, 13). The 
five dimensions of QoL that are examined in the MVQoLI-15 
are Symptoms, Function, Interpersonal, Well-Being and 
Transcendence. The total score of each dimension reflects 
the extent that this dimension affects the QoL of patients. 
Higher scores indicate better QoL. The average score of to-
tal QoL ranges from 0 to 30. This scale has been translated 
and culturally adapted to the Greek data (10). Psychometric 
properties of the Greek version have been studied (14, 15).
Fatigue Assessment Scale (FAS)
The second instrument was the Fatigue Assessment 
Scale (FAS). The original form of FAS was constructed in 
2003 and it consists of 10 questions (16) which collect infor-
mation related to the perceived fatigue. Five questions are 
related to Physical Fatigue and the other five to Mental Fa-
tigue. The responses rate on a 7 Likert point scale (1=never 
to 5=always). Consequently, the score varies between 10-
50. The patient’s responses to 10 questions are summed in 
order to construct the score. There are cutoff points which 
assist in recognizing who are fatigued, not- fatigued and 
extremely fatigued (17). Patients are categorized as “non-
fatigued” if the FAS score is below 22, “fatigued” if the FAS 
score is higher or equal to 22 and “extremely fatigued” if the 
FAS score is higher or equal to 35 (17). The FAS has been, 
also, used in patients with sarcoidosis (18), and under hemo-
dialysis (19). Psychometric properties of the Greek version 
have been studied among patients with chronic illness (19).
Pain Self-Efficacy Questionnaire (PSEQ)
The third instrument was the Pain Self-Efficacy Ques-
tionnaire (PSEQ). The PSEQ is a self-reported instrument 
which evaluates pain self-efficacy beliefs in patients with 
chronic pain. Each item is rated by selecting a number on a 
7 Likert point scale (0 = not at all confident to 6 = completely 
confident). A total score is calculated by summing the scores 
for each of the 10 items, yielding a maximum total score of 
60. Higher scores reflect stronger pain self-efficacy beliefs. 
The PSEQ has been used in patients undergoing hemodialy-
sis (20) in order to examine the psychometric properties of 
the Greek version (Cronbach’s Alpha 0,98) while in another 
study (21) QoL and pain self-efficacy were explored, also, 
among hemodialysis patients.
Sociodemographic elements (gender, age, marital status, 
education, working environment, years under therapy and years 
of having MS) were recorded.
Statistical analysis
In this study, a statistical analysis was made in order 
to measure the variables. Concerning the descriptive sta-
tistics, frequencies were made in each variable. Spearman 
rho test was performed in order to explore patterns of 
correlations between the dimensions of QoL, Fatigue, and 
Pain Self-Efficacy. In addition, simple and multiple linear 
regression models were performed in order to investigate 
if fatigue and pain self-efficacy could predict each dimen-
sion of QoL. Kruskal- Wallis test was performed in order to 
evaluate the dimensions of the variables with sociodemo-
graphic characteristics and examine if there are statistical 
differences. The IBM SPSS Statistics 21 was used to analyze 
the data and the level of significance was set up to .001.
Ethical considerations
The study was conducted according to the ethical 
standards of the Helsinki Declaration of 1975, as revised 
in 2000. After having received the Ethical approval from 
the Scientific Council of the “Agioi Anargyroi” Hospital 
of Kifissia (10/02/2018), individuals were informed by the 
researchers about the study, the voluntary participation, 
the anonymity, the withdraw rights and, also, that the ap-
proval has been given for this study. The anonymity of the 
participants was protected and the results obtained were 
used solely for scientific purposes. Signed informed consent 
was obtained from all individuals.
4. RESULTS
Descriptive statistics showed that 77.6% of the individu-
als participated in the study were females (n=66) and 22.4% 
were males (n=19). The mean age of the patients was 40.02 
years (Table 1).
The mean score of MVQoLI-15 was 45.65 (SD ±34.11), the 
mean score of PSEQ was 41,34 (SD±11.21) while the mean FAS 
score was 24.27 (SD±3.54) (Table 2). A percent of 12.9% (n=11) 
of patients were not-fatigued, 84.7% (n=72) were fatigued and 
2.35% (n=2) were extremely fatigued.
A series of Spearman’s rho correlations were conducted in or-
der to evaluate the differences between the research’s variables. 
As the below table reports (Table 3), strong positive correlations 
were found between Total Fatigue and Physical Fatigue (ρ(85)= 
0.87, p<0.01), Total Fatigue and Mental Fatigue (ρ(85)= 0.76, 
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p<0.01), Interpersonal and Pain (ρ(85)= 0.67, p<0.01).
A standard simple linear regression was employed to de-
termine if fatigue scores significantly predict the domains of 
MVQoLI-15. The overall model was significant (F [1, 83] = 4.18, 
p= 0.044) at function, explaining the 4% (R2 =0.04) of the vari-
ance (or 0.04 adjusted R2) in Fatigue scores. Fatigue is a negative 
weak significant predictor of Function (Beta = -0.22, t = -2.05, 
p= 0.044), suggesting that patients who experience low levels 
of fatigue have better functioning.
Multiple linear regressions were run to determine if pain 
self-efficacy scores significantly predict the domains of QoL. 
The overall model was significant (F [3, 81] = 29.89, p ≤0.001) 
at Transcendent, Interpersonal, and Well-being, explaining 
the 53% (R2 = 0.53) of the variance (or 0.51 adjusted R2) in Pain 
Self- Efficacy scores. Of the three predictors, only the domain 
of Interpersonal was a significant moderate positive predictor 
of Pain Self-Efficacy (Beta = 0.51, t = 5.19, p≤ 0.001), suggesting 
that patients with high levels of Pain Self- Efficacy scores have 
also, better interpersonal relationships. Transcendent (Beta = 
0.21, t = 1.65, p=0.102) and Well-being (Beta = 0.09, t = 0.72, p= 
0.475) were positive weak non-significant predictors of pain.
According to the Kruskal-Wallis test there was a statistically 
significant difference in Interpersonal score between the differ-
ent family status (H(4)= 13.25, p=0.01) with a mean rank Inter-
personal score of 29.95 for unmarried who live alone, 49.75 for 
married with no kids, 45.73 for unmarried who live with their 
parents, 37.78 for married with kids and 59.44 for unmarried who 
live with their partner. In addition, a statistically significant dif-
ference was also observed in the Transcendent score between 
the different family status (H(4)= 16.32, p=0.00) with a mean 
rank Transcendent score of 31.18 for unmarried who live alone, 
48.94 for married with no kids, 45.09 for unmarried who live with 
their parents, 36.51 for married with kids and 62.53 for unmar-
ried who live with their partner. There was not found any other 
statistically difference for the rest dimensions of QoL, such as 
the Symptom, the Function and the Well- being.
5. DISCUSSION
The purpose of the present study was to explore the 
relationship between fatigue, pain self-efficacy and QoL 
among patients with MS. Previous research evidence shows 
that fatigue associated with MS is related to a decrease in 
the QoL of these patients. The findings of this research are 
in accordance with the results of previous studies as there 
is a significant relationship with the aspects of QoL and 
the factor of fatigue. This study shows that fatigue has a 
considerable impact on the QoL in MS patients, their physi-
cal and mental health. Previous studies that explored the 
N %
Age, Mean (SD)1 40.02 (8.8)
Gender
Male 19 22,4
Female 66 77.6
Marital 
Status
Unmarried (live alone) 11 12.9
Unmarried (live with a partner) 16 18.8
Unmarried (live with parents) 11 12.9
Married (no children) 8 9.4
Married (with children) 39 45.9
Educational 
level
Primary & Secondary School 8 9.4
High School 28 33
University Graduate 45 53
MSc-PhD 4 4.7
Occupati-
onal Status
Unemployed 16 18.8
Part-time 6 7.1
Full-time 42 49.4
Retired 21 24.7
Table 1. Demographic characteristics of patients (N=85 
SD=Standard Deviation
M SD Minimum Maximum
Total MVQoLI-15 45,65 34.11 -33 104
Symptom 9.49 4.01 4 18
Function -0.26 10.99 -24 20
Interpersonal 14.21 13.31 -16 30
Well-being 5.42 14.45 -20 30
Transcendent 17.93 10.38 -4 30
Fatigue 24.27 3.54 17 31
Physical fatigue 13.11 2.51 8 18
Mental Fatigue 1.79 1,79 7 15
Pain Self- Efficacy 41.34 11.21 9 60
M= Mean, SD= Standard Deviation
Table 2. Means and Standard Deviations on the dimensions of 
Quality of life, Fatigue and Pain self- efficacy in MS patients 
(N=85)
Variables 1 2 3 4 5 6 7 8 9
1. Symptom -
2. Function 0.08 -
3.Interpersonal 0.11 0.04 -
4. Well-being -0.07 -0.05 0.60b -
5.Transcendent 0.03 -0.03 0.64b 0.76b -
6. Pain Self- Efficacy 0.06 -0.00 0.67b 0.50b 0.51b -
7. Fatigue (Total Score) 0.04 -0.27a 0.03 0.05 0.06 0.02 -
8. Mental Fatigue -0.010 -0.29b -0.14 -0.08 -0.05 -0.01 0.76b -
9. Physical Fatigue 0.07 -0.19 0.06 0.11 0.04 -0.00 0.87b 0.44b -
Table 3. Intercorrelations for all variables- Spearman’s rho. ap<0.05, bp<0.01
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QoL of MS patients indicated that patients with secondary 
progressive MS had a lower score on the scales of QoL in 
comparison to those with the relapsing-remitting form of 
MS (22). Published studies (23) showed that patients with 
fatigue had a considerably poorer QoL, regardless of physi-
cal disability and clinical course of the disease. The main 
interpretation of this finding is that fatigue can strongly 
influence performing the daily activities and as a result 
become a major reason for unemployment (24). As the find-
ings of Mc Cabew and De Judicibus (25) indicated that the 
pressures lead to changes in the economic situation, dealing 
with this pressure is momentous for QoL for MS patients.
In our study, there is a negative significant correlation be-
tween Mental Fatigue and the dimension of the QoL Function. 
Individuals with MS show reductions on measures of verbal 
memory (26). Mental fatigue can affect function in all its cases 
whether is about cerebral function or bodily function. In addi-
tion, MS patients report increased mental and physical fatigue 
(26). In a similar study, researchers found that the more physically 
active a patient is the lower levels of fatigue can be presented 
(27). The researchers support that those who reported low levels 
of fatigue, reported higher levels of QoL and function and as a 
result, the low levels of fatigue can predict better function in ev-
eryday life (28). According to the findings of this study, fatigue in 
MS is strongly correlated with Mental and Physical Fatigue. Most 
of MS patients report fatigue as the worst symptoms indicating, 
also, that fatigue has a significant effect on the mental health 
and general health status of MS patients (29).
Regarding the effect of pain self-efficacy on QoL, it was found 
that pain self-efficacy may predict the dimension of QoL Inter-
personal. This is a very satisfactory finding based on common 
sense. When an individual tries and deals with the pain that ef-
fort leads to be more active, more friendly and companionable 
as a result build more meaningful and purposeful interpersonal 
relationships. Previous findings support that high levels of pain 
self-efficacy can lead to high levels of social support and, as a 
result, high levels of interpersonal relationships (28). Our results 
may be linked with previous findings which support that good 
and healthy relationships release endorphins which relieve 
pain and as a result, there is more pain tolerance and more pain 
self- efficacy (29).
Our study revealed that people who were married with chil-
dren experience more fatigue than the others who either are 
unmarried and live with their partners or live alone. That is quite 
reasonable if we think that when married parents have kids, at 
the same time they have more responsibilities and more worries 
than the others who don’t have kids or are singles. In a study 
(30) focused on the characteristics of chronic fatigue and the dif-
ference between the duration of fatigue and the characteristics 
of chronic fatigue, participants in the younger age group were 
more energetic than the women and those in other age groups 
(30). In addition, married people experienced more fatigue than 
people who were single, divorced or separated (30). Our finding 
is supported by Mollaoğlu and Üstün (30) who in their research 
emphasize that fatigue is affected by factors such as age, gender, 
education, and marital status.
The current study has acquired several strengths through 
its completion. The most important contribution of the pres-
ent study is the fact that in the international literature there is 
only one study (40) examining the correlation of these variables 
(fatigue, pain self-efficacy, and QoL) among MS patients. On the 
other hand, the results cannot be generalized as the sample of 
the study come from one hospital even “Ag. Anargyroi” Hospi-
tal is one of the largest hospitals in Athens region. In addition, 
participants were being hospitalized patients and, therefore, 
the presence of other persons, employees and the burden of 
hospitalization may have influenced the answers.
6. CONCLUSION
Fatigue is a symptom that has a significant effect on 
the daily lives of patients suffering from MS. Additional 
research in the direction of measurement and pathogenesis 
of fatigue will hopefully lead to improved therapies. Pain 
in MS has to be taken into serious consideration in every 
MS patient and adapted treatments strategies must be pre-
scribed. Health professionals should point to increasing the 
patient’s perceived social support and QoL, advising the 
patient’s family and, also, increase the patient’s self- ef-
ficacy levels. This communication leads to a strong health 
professional-patient relationship with better QoL and bet-
ter health outcomes.
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